Can a simple questionnaire spot how rheumatic lung disease affects daily life?
NCT ID NCT07700004
First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time
Summary
This study checks whether the King's Brief Interstitial Lung Disease Questionnaire (K-BILD) works accurately in Turkish for people whose lung problems stem from rheumatic diseases like arthritis. Researchers will compare the K-BILD results with other health surveys to see if it reliably measures quality of life and breathing difficulties. The goal is to give doctors a validated tool to better understand and manage these patients' symptoms.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If the questionnaire proves reliable, doctors may have a better tool to measure how lung problems affect daily life in Turkish-speaking patients with rheumatic diseases.
- What could go wrong
- This is a small, early-stage validation study with only 45 participants. The questionnaire may not capture all important aspects of the disease or may not work well in broader populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 45 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jul 2026
An estimate. Start dates often move.
- Expected to finish
-
May 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All patient-reported outcome measurements will be administered once, and King's Brief Interstitial Lung Disease Questionnaire will be administered twice, one week apart.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria:-Having been diagnosed with interstitial lung disease by a rheumatologist, * Being 18 years of age or older, * Agreeing to participate in the study. Exclusion Criteria:- Presence of a neurological disease * Presence of any orthopedic problem that affects functionality * History of any orthopedic surgery in the last year * Inability to speak or understand Turkish fluently * Presence of a psychiatric illness that affects cooperation * Heart failure that affects daily living activities * Being a cancer patient
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Interstitial lung disease due to systemic disease are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Usak University
Uşak, Center, 64200, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.